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1. Introduction 
In our research about the physiological importance 
of 5hydroxytryptamine we have isolated and analyzed 
vesicles and synaptic membranes from rat brain in or- 
der to get information for the possible classification 
of this amine as a synaptic transmitter. In this letter 
we present evidence that one vesicle fraction and the 
synaptic membranes contain the highest amount of 
5-HT * from all brain fractions analyzed. These results 
are compatible with the concept that 5-HT - as a 
possible transmitter substance like acetylcholine and 
norepinephrine - must be stored or synthesized in the 
presynaptic terminals and must be bound to the sub- 
synaptic membranes. 
2. Methods 
Vesicles and synaptic membranes were isolated 
from rat brain by differential- and sucrose gradient 
centrifugation as described in fig. 1. This is a modifi- 
cation of the methods first published by De Robertis 
[l-3] and Whittacker [4,5]. Protein was assayed with 
the biuret reaction [6], 5-HT fluorimetrically by the 
method of Bogdansky [7], and SDH with cytochrome 
c as electron acceptor according to Kadenbach [8]. 
Sialic acids were determined with thiobarbituric acid 
[9] as N-acetyl-neuraminic acid after 1 hr hydrolysis 
* Abbreviations: S-HT = 5hydroxytryptamine (s rotonin); 
NeuNAc = N-acetylneuraminic a id; SDH = succinate de- 
hydrogenase (EC. 1.3.99.1). 
with 0.1 N H2SO4 at 80” using N-acetylneuramin- 
lactose as reference. The number ahd size of vesicles 
were determined exponentially from electron micro- 
graphs of ultrathin sections by means of a “Teilchen- 
gr6ssenz?ihlger8t7’ from Zeiss. Vesicle suspensions con- 
taining 0.3-0.6 mg protein/ml were incubated with 
S-hydroxytryptamine-3-14C-creatinine sulphate (0.025 
&/ml; 4.9 mc/mmole; the Radiochemical Centre, 
Amersham, Bucks.) at 37”C, in 0.01 M potassium 
phosphate-o. 15 M KC1 buffer (pH 8). At different 
times aliquots of the incubation mixture were centri- 
fuged and the loss of radioactivity in the supernatant 
was taken as a measure of 5-HT uptake by the vesicles. 
Thin-layer chromatography was achieved on Kiesel- 
gel G, Merck, coated plates with CHCl,/Me/ 12.5% 
NH3 (60:40:9) and Propanol/l2.5% NH, (7:3) as 
solvents. 
3. Results and discussion 
The analysis of all fractions obtained during the 
isolation of the vesicles (table 1) shows that the 
106,000 X g precipitate - the “crude” vesicle frac- 
tion (fraction 6) - still contains SDH activity which 
is due to mitochondrial fragments. After further puri- 
fication of this fraction by centrifugation on a simple 
H20/0.4 M sucrose gradient a vesicle fraction free of 
SDH activity was collected just below the water/ 
sucrose interface. This “purified” vesicle fraction con- 
tains 0.31 nMo1 5-HT/mg protein. Thus the 5-HT con- 
centration is raised 6-fold by this purification step, 
while the NeuNAc concentration falls by about 40%. 
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Fig. 1. Isolation of vesicles and synaptic membranes from rat brain. 
(4 (b) 
Fig. 2. Electron micrographs of the vesicles isolated from rat brain. 
(a) “Crude” vesicle fraction. (b) “Purified” uesicle fraction; 10,000 X 3%. 
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Table 1 
Analysis of the different brain fractions (obtained according to fig. 1). 
Fraction 
Protein 
(mg/g fresh) 
SDH t 
nMol/min 
r. sp. a. * 
mg protein 
S-HT t NeuNAc ‘t 
nMo1 
r. sp. c. ** 
nMo1 
mg protein mg protein 
r. sp. c. ** 
1) homogenate (total brain) 
2) nuclear fraction 
3) microsomes 
4) mitochondria, synaptosomes 
5) mitochondria, ruptured 
nerve endings 
6) “crude” vesicle fractiob 
7) soluble fraction (super- 
natant 6) 
8) “purified” vesicles 
9) membrane fragments, 
swollen mitochondria 
100 (32) t 10.8 (26) 1 
10.9 (18) 8 (13) 1.2 
47.2 (18) 0.8 (13) 0.1 
24.9 (18) 20 (13) 1.5 
11.9 (31) 49.2 (26) 3.5 
4.4 (18) 10 (13) 3.1 
5.9 (18) - (13) - 
0.26 (26) - (20) - 
2.1 (18) 9 (13) 2.6 
0.02 (26) 1 
0.03 (13) 0.7 
0.02 (13) 0.8 
0.02 ( 13) 1.3 
0.02 (22) 0.8 
0.05 (13) 1.1 
0.05 (13) 1.9 
0.31 (20) 21 
0.02 (13) 1.1 
23.4 (23) 
13.9 (10) 
25.4 (10) 
24.3 (10) 
17.4 (23) 
33.0 (10) 
10.0 (10) 
20.6 (21) 
34.2 (10) 
1 
0.6 
1.1 
1.1 
0.7 
1.8 
0.5 
0.7 
0.5 
* r. sp. a. = relative specific avtivity = %SDH/%protein 
** r. sp. c. = relative specific concentration = % substrate/% protein 
5 The number of experiments is given in parentheses 
Table 2 
Analysis of the synaptic membranes 
Fraction 
Protein 
(mg/g fresh) 
SDH 5-HT NeuNAc 
nMol/min 
r. sp. a. * 
nMo1 nMo1 
mg protein mg protein 
r. sp. c. ** 
mg protein 
r. sp. c. ** 
1) homogenate (total brain) 
5) mitochondria, ruptured 
nerve endings 
1) 0.8 M sucrose 
II) 0.9 M sucrose 
III) 1.0 M sucrose, myelin, 
synaptic membranes 
IV) 1.2 M sucrose 
synaptic membranes 
V) precipitate 
swollen mitochondria 
100 (32) t 10.8 (26) 1 0.02 (26) 1 23.4 (23) 1 
11.9 (31) 49.2 (26) 3.53 0.02 (22) 0.8 17.4 (23) 0.7 
2.8 (14) 1.9 >(13) 0.18 0.02 (13) 1.1 12.7 (13) 0.5 
1.0 (14) 2.4 >(13) 0.24 0.02 (13) 1.9 15.7 (13) 0.5 
0.7 (14) 2.4 >(13) 0.18 0.04 (13) 2.2 15.3 (13) 0.6 
1.1 (14) 8.8 >(13) 0.70 0.05 (13) 4.5 11.0 (13) 0.3 
3.9 (14) 146.7 (13) 10.94 0.01 (13) 0.7 5.7 (13) 0.2 
* r. sp. a. = relative specific activity = % SDH/% protein 
** r. sp. c. = relative specific concentration = % substrate/% protein 
t The number of experiments is given in parentheses. 
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Fig. 3. Size distribution and summation curve of “purified” 
vesicles. The number of particles which had been counted 
was 1589 ( -) and 1370 (------). x---_-x size distribu- 
tion curve, (J- --_-- c) summation curve. 
Extraction of the vesicles with chloroform/methanol 
(2: 1) followed by centrifugation yielded a NeuNAc 
free supernatant. The total amount of NeuNAc was 
found in the precipitate in a bound form. Gangliosides 
were not detected on thin-layer chromatograms of the 
purified vesicle fraction. These results exclude the 
presence of gangliosides in the vesicles isolated by the 
procedure described above. We assume that NeuNAc 
is bound to a glycoprotein. Our findings are in good 
agreement with recent results from Whittacker [lo] 
and Wiegandt [l I]. In contrast to Burton et al. [ 12,131 
these authors did not find any or almost no ganglio- 
side-bound NeuNAc in their vesicle fractions. Though 
the protein content of the crude vesicle fraction - 
4.4 mg/g fresh weight - agrees rather well with the 
results of other authors - De Robertis [ 141: 4.4 mg/ 
g fresh weight; Burton [ 121: 2 mg/g fresh weight - 
the purified vesicles contain only about I/ 10 of this 
concentration. 
After resuspending and centrifugation of the pre- 
cipitate containing mitochondria and ruptured nerve 
endings [see fig. 1 (fraction 5)!] in a discontinuous 
sucrose gradient ranging from 0.8-l .2 M 4 fractions 
and a precipitate of swollen mitochondria are ob- 
tained (table 2). Fraction IV contains synaptic mem- 
branes and a few small mitochondria as demonstrated 
by electron-microscopy and SDH activity. 
Electron-micrographs of the “crude” (fig. 2a) and 
“purified” vesicle fraction (fig. 2b) are in accordance 
with the described analytical differences. The more 
uniform appearance of the “purified” vesicles as com- 
pared with the “crude” fraction is due to an enrich- 
ment of vesicles. The size distribution curve (fig. 3) of 
the “purified” vesicles ranges from about 500- 1300 8, 
revealing a maximum at 735 A with two shoulders at 
600 and 890 A which indicates three main particle 
sizes. According to the summation curve (fig. 3) about 
3% of the “purified” vesicles fall in the range 300- 
500 A contrasted with about 55% of the “synaptic” 
vesicles as described in the literature [ 141. About 40% 
of the “purified” vesicles have a diameter between 
700 and 900 A. These results clearly indicate a differ- 
ence of chemical composition and morphology be- 
tween both vesicle preparations. 
The binding of 5-HT to the vesicle fraction was 
studied with 5-hydroxytryptamine-3-14C (5 X lo6 M). 
It is time-dependent and reveals two plateaus: the first 
plateau was obtained after 10 min of incubation where 
a total of 0.44 nmole 5-HT/mg protein was incorpo- 
rated. After a further increase in the rate of binding a 
second plateau was reached where a total of 0.85 
mnole 5-HT/mg protein was incorporated after 120 
min of incubation. Further work has to clarify whe- 
ther these two plateaus are due to different binding 
constants of one vesicle species or whether 5-HT is 
incorporated into different kinds of particles of the 
vesicle fraction. 
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